Having been a Project Manager on Oil and Gas plants and seen first hand the difficulties in bring projects to completion, I think the logical way to progress with this company is to form a solid partnership with an industrial construction company. This would enable them to bid for contracts on a turnkey basis.
1Day Sooner is launching a UK campaign this week with a petition to parliament asking for public funding of a biocontainment facility with enough capacity to quarantine 100 to 200 participants. Taken from FT article. I hope CF is a few steps ahead of this!
After the 2nd day of carnage this is as strong as ever. I have bought again today. Nothing has changed and as long as CF is the Captain of this ship I'm staying aboard. Trust him he is shareholder savvy and has too much skin in the game to upset the apple cart. Goodnight and think positive
Did anyone spot this at the end of todays RNS22 Sep 2020 07:47
"WEARABLES" Open Orphan comprises of two commercial specialist CRO services businesses, hVIVO and Venn Life Sciences and is also building out a valuable data platform business. hVIVO has built up one of the world's largest databases of infectious disease progression data and we are populating our Open Orphan Health Data platform with this historical hVIVO data. In our clinical trials going forward, we are also planning to collect data on volunteer's via wearables during clinical trials. Therefore, Open Orphan's data, which may yield valuable digital biomarkers, could be one of the more sought-after datasets by many of the large wearables /smart watch wearables providers around the world. In June 2019, Open Orphan acquired AIM-listed Venn Life Sciences Holdings plc in a reverse take-over and in January 2020 it completed the merger with hVIVO plc in January 2020. Venn is an integrated drug development consultancy firm which offers CMC (chemistry, manufacturing and controls), preclinical, Phase I & II clinical trials design and execution. The merger with hVIVO created a European full pharma services company broadening the Company's customer base and with complementary specialist CRO services, widened the range of the Company's service offerings.